Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/86060
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study |
| Author: | Baccarani, M. Druker, B. Branford, S. Kim, D. Pane, F. Mongay, L. Mone, M. Ortmann, C. Kantarjian, H. Radich, J. Hughes, T. Cortes, J. Guilhot, F. |
| Citation: | International Journal of Hematology, 2014; 99(5):616-624 |
| Publisher: | Springer Japan |
| Issue Date: | 2014 |
| ISSN: | 0925-5710 1865-3774 |
| Statement of Responsibility: | Michele Baccarani; Brian J. Druker; Susan Branford; Dong-Wook Kim; Fabrizio Pane; Lidia Mongay; Manisha Mone; Christine-Elke Ortmann; Hagop M. Kantarjian; Jerald P. Radich; Timothy P. Hughes; Jorge E. Cortes; François Guilhot |
| Abstract: | Abstract not available |
| Keywords: | Imatinib; Chronic myeloid leukemia; Phase 3 clinical trial; BCR-ABL; Tyrosine kinase inhibitor |
| Rights: | © The Japanese Society of Hematology 2014 |
| DOI: | 10.1007/s12185-014-1566-2 |
| Published version: | http://dx.doi.org/10.1007/s12185-014-1566-2 |
| Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.